Innoviva (INVA) Cash from Investing Activities (2010 - 2026)
Innoviva posted quarterly Cash from Investing Activities of $37.0 million for Q1 2026, up 206.73% year-on-year from $12.1 million in Q1 2025, and up 119.5% on a QoQ basis from $16.9 million in Q3 2025.
Innoviva (INVA) has 17 years of Cash from Investing Activities data on file, last reported at $37.0 million in Q1 2026.
- For the quarter ending Q1 2026, Cash from Investing Activities rose 206.73% year-over-year to $37.0 million; the trailing twelve-month figure through Mar 2026 stood at $52.3 million (up 141.51% YoY), and the FY2025 full-year result was $40.5 million, up 163.49% from the prior year.
- Cash from Investing Activities for Q1 2026 stood at $37.0 million, up from $16.9 million in the prior quarter.
- Across five years, Cash from Investing Activities topped out at $37.0 million in Q1 2026 and bottomed at -$143.2 million in Q1 2022.
- The 5-year median for Cash from Investing Activities is -$35.7 million (2023), against an average of -$30.0 million.
- The widest annual swing landed in 2022, when Cash from Investing Activities slumped 442.38%; it then soared 206.73% in 2026.
- A 5-year view of Cash from Investing Activities shows it stood at -$48.0 million in 2022, then retreated by 28.47% to -$61.6 million in 2023, then gained by 21.59% to -$48.3 million in 2024, then surged by 134.9% to $16.9 million in 2025, then surged by 119.5% to $37.0 million in 2026.
- The last three Cash from Investing Activities figures came in at $37.0 million (Q1 2026), $16.9 million (Q3 2025), and $33.1 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -2.89 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 638.50 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -431.90 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -428.90 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -25.54 Mn |
| 10 | Innoviva | 1.60 Bn | 992.84 Mn | 75.83 Mn | 37.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 37.01 Mn |
| Mar 31, 2026 | 37.01 Mn |
| Sep 30, 2025 | 16.86 Mn |
| Sep 30, 2025 | 16.86 Mn |
| Jun 30, 2025 | 33.12 Mn |
| Jun 30, 2025 | 33.12 Mn |
| Mar 31, 2025 | -34.67 Mn |
| Mar 31, 2025 | -34.67 Mn |
| Sep 30, 2024 | -48.31 Mn |
| Sep 30, 2024 | -48.31 Mn |
| Mar 31, 2024 | -43.04 Mn |
| Mar 31, 2024 | -43.04 Mn |
| Sep 30, 2023 | -61.61 Mn |
| Sep 30, 2023 | -61.61 Mn |
| Mar 31, 2023 | -35.72 Mn |
| Mar 31, 2023 | -35.72 Mn |
| Sep 30, 2022 | -47.96 Mn |
| Sep 30, 2022 | -47.96 Mn |
| Jun 30, 2022 | -2.52 Mn |
| Jun 30, 2022 | -2.52 Mn |
| Mar 31, 2022 | -143.16 Mn |
| Mar 31, 2022 | -143.16 Mn |
| Sep 30, 2021 | 63.63 Mn |
| Sep 30, 2021 | 63.63 Mn |
| Jun 30, 2021 | 90.02 Mn |
| Jun 30, 2021 | 90.02 Mn |
| Mar 31, 2021 | -26.39 Mn |
| Mar 31, 2021 | -26.39 Mn |
| Dec 31, 2020 | -315.48 Mn |
| Dec 31, 2020 | -315.48 Mn |
| Sep 30, 2020 | -8.50 Mn |
| Sep 30, 2020 | -8.50 Mn |
| Jun 30, 2020 | -7.00 Mn |
| Jun 30, 2020 | -7.00 Mn |
| Mar 31, 2020 | 16.04 Mn |
| Mar 31, 2020 | 16.04 Mn |
| Dec 31, 2019 | 51.99 Mn |
| Dec 31, 2019 | 51.99 Mn |
| Sep 30, 2019 | -15.94 Mn |
| Sep 30, 2019 | -15.94 Mn |
| Jun 30, 2019 | 20.11 Mn |
| Jun 30, 2019 | 20.11 Mn |
| Mar 31, 2019 | -74.17 Mn |
| Mar 31, 2019 | -74.17 Mn |
| Dec 31, 2018 | -45.59 Mn |
| Dec 31, 2018 | -45.59 Mn |
| Sep 30, 2018 | 13.52 Mn |
| Sep 30, 2018 | 13.52 Mn |
| Jun 30, 2018 | 9.08 Mn |
| Jun 30, 2018 | 9.08 Mn |
| Mar 31, 2018 | 26.51 Mn |
| Mar 31, 2018 | 26.51 Mn |
| Dec 31, 2017 | -25.88 Mn |
| Dec 31, 2017 | -25.88 Mn |
| Sep 30, 2017 | -21.77 Mn |
| Sep 30, 2017 | -21.77 Mn |
| Jun 30, 2017 | 2.02 Mn |
| Jun 30, 2017 | 2.02 Mn |
| Mar 31, 2017 | 22.40 Mn |
| Mar 31, 2017 | 22.40 Mn |
| Dec 31, 2016 | 23.32 Mn |
| Dec 31, 2016 | 23.32 Mn |
| Sep 30, 2016 | -15.10 Mn |
| Sep 30, 2016 | -15.10 Mn |
| Jun 30, 2016 | -24.50 Mn |
| Jun 30, 2016 | -24.50 Mn |
| Mar 31, 2016 | 11.69 Mn |
| Mar 31, 2016 | 11.69 Mn |
| Dec 31, 2015 | 99.29 Mn |
| Dec 31, 2015 | 99.29 Mn |
| Sep 30, 2015 | -47.88 Mn |
| Sep 30, 2015 | -47.88 Mn |
| Jun 30, 2015 | 34.05 Mn |
| Jun 30, 2015 | 34.05 Mn |
| Mar 31, 2015 | 73.71 Mn |
| Mar 31, 2015 | 73.71 Mn |
| Dec 31, 2014 | -8.41 Mn |
| Dec 31, 2014 | -8.41 Mn |
| Sep 30, 2014 | -59.55 Mn |
| Sep 30, 2014 | -59.55 Mn |
| Jun 30, 2014 | -11.23 Mn |
| Jun 30, 2014 | -11.23 Mn |
| Mar 31, 2014 | 14.13 Mn |
| Mar 31, 2014 | 14.13 Mn |
| Dec 31, 2013 | -1.43 Mn |
| Dec 31, 2013 | -1.43 Mn |
| Sep 30, 2013 | -99.61 Mn |
| Sep 30, 2013 | -99.61 Mn |
| Jun 30, 2013 | -73.53 Mn |
| Jun 30, 2013 | -73.53 Mn |
| Mar 31, 2013 | -45.01 Mn |
| Mar 31, 2013 | -45.01 Mn |
| Dec 31, 2012 | 146,000.00 |
| Dec 31, 2012 | 146,000.00 |
| Sep 30, 2012 | -33.71 Mn |
| Sep 30, 2012 | -33.71 Mn |
| Jun 30, 2012 | -33.10 Mn |
| Jun 30, 2012 | -33.10 Mn |
| Mar 31, 2012 | 8.38 Mn |
| Mar 31, 2012 | 8.38 Mn |
| Dec 31, 2011 | 4.55 Mn |
| Dec 31, 2011 | 4.55 Mn |
| Sep 30, 2011 | -9.90 Mn |
| Sep 30, 2011 | -9.90 Mn |
| Jun 30, 2011 | -49.23 Mn |
| Jun 30, 2011 | -49.23 Mn |
| Mar 31, 2011 | -1.24 Mn |
| Mar 31, 2011 | -1.24 Mn |
| Dec 31, 2010 | -18.03 Mn |
| Dec 31, 2010 | -18.03 Mn |
| Sep 30, 2010 | 11.19 Mn |
| Sep 30, 2010 | 11.19 Mn |